Last update 21 Nov 2024
BCG Vaccine(Chengdu Coen Biotechnology)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Oncolytic bacteria, Live attenuated vaccine, Therapeutic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with BCG Vaccine(Chengdu Coen Biotechnology)一项评估治疗用卡介苗（BCG）预防中、高危非肌层浸润性膀胱癌术后复发的有效性和安全性的多中心、随机、双盲、阳性对照的Ⅲ期临床研究
[Translation] A multicenter, randomized, double-blind, positive-controlled phase III clinical study to evaluate the efficacy and safety of therapeutic Bacillus Calmette-Guérin (BCG) in preventing postoperative recurrence of intermediate- and high-risk non-muscle invasive bladder cancer
Phase III Multi-center Randomized, Double-blind and Positive-controlled Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
一项考察治疗用卡介苗在中、高危非肌层浸润性膀胱癌（NMIBC）受试者术后辅助治疗中安全性和耐受性的Ⅰ期临床研究
[Translation] A phase I clinical study to investigate the safety and tolerability of therapeutic BCG in the adjuvant treatment of subjects with intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC) after surgery
100 Clinical Results associated with BCG Vaccine(Chengdu Coen Biotechnology)
Login to view more data
100 Translational Medicine associated with BCG Vaccine(Chengdu Coen Biotechnology)
Login to view more data
100 Patents (Medical) associated with BCG Vaccine(Chengdu Coen Biotechnology)
Login to view more data
100 Deals associated with BCG Vaccine(Chengdu Coen Biotechnology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bladder papilloma | Phase 3 | CN | 03 Jan 2024 | |
| Carcinoma in situ of bladder | Phase 3 | CN | 03 Jan 2024 | |
| Non-Muscle Invasive Bladder Neoplasms | Phase 3 | CN | 28 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free